0001171843-15-000644.txt : 20150205 0001171843-15-000644.hdr.sgml : 20150205 20150205170433 ACCESSION NUMBER: 0001171843-15-000644 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150203 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anika Therapeutics, Inc. CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: (781) 457-9000 MAIL ADDRESS: STREET 1: 32 WIGGINS AVENUE CITY: BEDFORD STATE: MA ZIP: 01730 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC DATE OF NAME CHANGE: 19970114 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERWOOD CHARLES H CENTRAL INDEX KEY: 0001244298 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 15580957 4 1 gff4_sherwood020515.xml OWNERSHIP DOCUMENT X0306 4 2015-02-03 0 0000898437 Anika Therapeutics, Inc. ANIK 0001244298 SHERWOOD CHARLES H 32 WIGGINS AVENUE BEDFORD MA 01730 1 1 0 0 President and CEO Common Stock 2015-02-03 4 A 0 13500 0 A 191455 D Common Stock 2015-02-04 4 A 0 50000 8.71 A 241455 D Stock Option (Right to Buy) 39.69 2015-02-03 4 A 0 34200 0 A 2025-02-03 Common Stock 13700 34200 D Stock Option (Right to Buy) 32.02 2015-02-03 4 A 0 16600 0 A 2024-01-27 Common Stock 16600 16600 D Stock Option (Right to Buy) 8.71 2015-02-04 4 M 0 50000 0 D 2015-02-10 Common Stock 50000 0 D Restricted stock awards vest in four equal annual installments beginning February 3, 2016. Exercise of stock options granted on February 10, 2005 with an expiration date of February 10, 2015. The stock options vest in four equal annual installments beginning February 3, 2016. The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2014, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 5 and 6. On February 3, 2015, the Compensation Committee modified the performance measures under the Performance Grant and determined that under the modified performance measures 100% of the performance grant had been earned, subject to time-based vesting. Please also see notes 4 and 6. The stock options vest in four equal installments on the following dates: February 3, 2015, January 1, 2016, January 1, 2017 and January 1, 2018. /s/ Charles H. Sherwood, Ph. D. 2015-02-05